Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-03-09 @ 4:04 AM
Study NCT ID:
NCT02077933
Status:
COMPLETED
Last Update Posted:
2020-12-08
First Post:
2014-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-28
First Submit QC Date:
None
Study First Post Date:
2014-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-04
Last Update Post Date:
2020-12-08
Last Update Post Date Type:
ACTUAL